Benefits
Standardized, Soluble HCA Source
Citrin® and Citrin K® provide a quality-controlled, standardized form of Garcinia cambogia HCA. The potassium/calcium salt in Citrin K® is designed for better water solubility and bioavailability, which is a formulation advantage rather than a proven efficacy advantage.
Appetite and Weight-Management Support
HCA is traditionally used to support appetite control and weight-management goals as part of a reduced-calorie diet. Honest context: controlled human trials are inconsistent, and the largest rigorous trial did not show benefit beyond placebo, so expectations should be modest.
Carbohydrate Metabolism Interest
HCA may influence how the body processes carbohydrates by acting on a key fat-synthesis enzyme in laboratory models. Whether this translates into meaningful body-composition change in humans remains unproven.
Calorie-Controlled Diet Adjunct
Citrin® is best positioned as an optional adjunct within a calorie-controlled diet and activity program, not as a stand-alone weight solution. Any effect on weight appears small and may not be clinically meaningful.
Mechanism of action
ATP-Citrate Lyase Inhibition
HCA competitively inhibits ATP-citrate lyase, the enzyme that converts citrate to acetyl-CoA for de novo fatty-acid synthesis. In animal models this can reduce lipogenesis, but the human relevance is uncertain given negative clinical outcomes.
Appetite/Satiety Signaling
HCA has been proposed to increase satiety, possibly via effects on serotonin availability and reduced de novo lipogenesis sparing carbohydrate for glycogen. Human appetite data are inconsistent across trials.
Salt Form and Bioavailability
Bound calcium or potassium/calcium salts improve HCA stability and aqueous solubility. The free-acid lactonizes readily; the salt forms (Citrin®, Citrin K®) are intended to deliver more active (-)-HCA to absorption sites.
Clinical trials
Twelve-week randomized, double-blind, placebo-controlled trial of Garcinia cambogia (1,500 mg HCA/day) vs placebo in 135 overweight adults on a high-fiber, low-energy diet.
135 overweight men and women.
Both groups lost weight, but the Garcinia/HCA group did not lose significantly more weight or fat than placebo. This widely cited result is the foundation for honest, cautious communication about HCA and weight loss.
Systematic review and meta-analysis of randomized clinical trials evaluating Garcinia extract (HCA) for body weight.
Pooled across HCA randomized trials.
The pooled analysis found only a small difference in weight favoring HCA over placebo, and the authors concluded the magnitude was small and the clinical relevance uncertain. Supports a measured, non-overstated benefit claim.
Twelve-week double-blind, randomized, placebo-controlled trial of Garcinia cambogia (1,000 mg HCA/day) vs placebo evaluating visceral fat in adults.
Adults with elevated visceral fat.
This trial reported a reduction in visceral fat area with HCA versus placebo, illustrating that some studies are positive while larger rigorous trials are not — reinforcing that the overall evidence base is mixed.